Source: MarketScreener

Arix Bioscience: RTW Biotech completes Arix investment in takeover run-up

(marketscreener.com) RTW Biotech Opportunities Ltd - New York-based investment firm focused on the life sciences sector - Says it completed on Friday its previously announced acquisition of a 25.5% stake in Arix Bioscience PLC for USD57.1 million, equivalent to GBP1.37 per Arix share. Purchase is to support its planned all-share acquisition of Arix's assets. Arix...https://www.marketscreener.com/quote/stock/RTW-BIOTECH-OPPORTUNITIES-74010978/news/RTW-Biotech-completes-Arix-investment-in-takeover-run-up-45785984/?utm_medium=RSS&utm_content=20240122

Read full article »
Annual Revenue
$100K-5.0M
Employees
1-25
Robert Lyne's photo - CEO of Arix

CEO

Robert Lyne

CEO Approval Rating

85/100

Read more